Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function
- PMID: 1672166
- PMCID: PMC240051
- DOI: 10.1128/JVI.65.4.2037-2046.1991
Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function
Abstract
The avian erythroblastosis virus v-erbA oncogene is imprecisely derived from a cellular gene (c-erbA) encoding a thyroid hormone receptor: the v-erbA protein has sustained both small terminal deletions and internal amino acid sequence changes relative to c-erbA. We report here that one of these missense differences between v- and c-erbA proteins, located in a zinc finger DNA binding domain, has dramatic effects on the biological activities of the encoded protein. Back mutation of the viral coding sequence to resemble c-erbA at this site severely impairs erythroid transformation and produces subtle changes in DNA binding by the encoded protein, suggesting that differences in DNA binding by the viral and cellular proteins may be involved in the activation of v-erbA as an oncogene.
Similar articles
-
v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.Cell. 1990 Jun 15;61(6):1035-49. doi: 10.1016/0092-8674(90)90068-p. Cell. 1990. PMID: 1972036
-
Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.J Biol Chem. 1991 Jun 25;266(18):11589-93. J Biol Chem. 1991. PMID: 1675637
-
A subpopulation of the avian erythroblastosis virus v-erbA protein, a member of the nuclear hormone receptor family, is glycosylated.J Virol. 1990 Jan;64(1):463-6. doi: 10.1128/JVI.64.1.463-466.1990. J Virol. 1990. PMID: 1967151 Free PMC article.
-
c-erbA: protooncogene or growth suppressor gene?Adv Cancer Res. 1992;59:89-113. doi: 10.1016/s0065-230x(08)60304-8. Adv Cancer Res. 1992. PMID: 1355627 Review. No abstract available.
-
ErbA: tumor suppressor turned oncogene?FASEB J. 1993 Jul;7(10):904-9. doi: 10.1096/fasebj.7.10.8102105. FASEB J. 1993. PMID: 8102105 Review.
Cited by
-
Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.EMBO J. 1992 Sep;11(9):3355-65. doi: 10.1002/j.1460-2075.1992.tb05414.x. EMBO J. 1992. PMID: 1354613 Free PMC article.
-
The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors.EMBO J. 1997 Jan 15;16(2):267-80. doi: 10.1093/emboj/16.2.267. EMBO J. 1997. PMID: 9029148 Free PMC article.
-
Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses.Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10633-7. doi: 10.1073/pnas.89.22.10633. Proc Natl Acad Sci U S A. 1992. PMID: 1359543 Free PMC article.
-
The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.Mol Cell Biol. 1993 Oct;13(10):5970-80. doi: 10.1128/mcb.13.10.5970-5980.1993. Mol Cell Biol. 1993. PMID: 8105369 Free PMC article.
-
A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).Mol Cell Biol. 1993 Jun;13(6):3675-85. doi: 10.1128/mcb.13.6.3675-3685.1993. Mol Cell Biol. 1993. PMID: 8098843 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources